Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2007
08/21/2007US7258874 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
08/21/2007US7258873 Preservation of bioactive materials by spray drying
08/21/2007US7258872 Chromone enteric release formulation
08/21/2007US7258871 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
08/21/2007US7258869 Capable of suspending beneficial agents and homogeneously dispensing them over an extended period of time at body temperature and at low flow rates; storage stability; injections; grafting; proteinaceous drugs; antiagglomerants
08/21/2007US7258851 Cholesterol reducing chewing gum composition and method of making the same
08/21/2007US7258850 Methods and compositions for treating erectile dysfunction
08/21/2007CA2541931C Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
08/21/2007CA2388610C Oral transmucosal drug dosage using solid solution
08/21/2007CA2387600C Novel fusidic acid derivatives
08/21/2007CA2345494C Methods and apparatus for improved administration of fentanyl and sufentanil
08/21/2007CA2341519C Gels and multilayer surface structures from boronic acid containing polymers
08/21/2007CA2332790C Controlled release lipoic acid
08/21/2007CA2303365C Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
08/21/2007CA2293622C Aerosol preparation
08/21/2007CA2288958C Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
08/21/2007CA2165995C Medicaments for the treatment of restenosis and arterial sclerosis
08/21/2007CA2155947C Methods for in vivo delivery of biologics and compositions useful therefor
08/17/2007CA2569776A1 Low flush niacin formulation
08/16/2007WO2007092829A2 Stabilized compositions of proteins having a free thiol moiety
08/16/2007WO2007092811A2 Sialagogue based oral care products
08/16/2007WO2007092784A1 Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
08/16/2007WO2007092755A2 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
08/16/2007WO2007092717A1 Latex or pseudolatex compositions coatings and coating processes
08/16/2007WO2007092642A2 Polymer formulations of cetp inhibitors
08/16/2007WO2007092284A2 Low dose no donor-containing transdermal patch
08/16/2007WO2007092207A1 Compositions for the delivery of substituted naphthyl indole derivatives and methods of their use
08/16/2007WO2007092161A2 A direct cellular energy delivery system
08/16/2007WO2007092158A1 Ultrasound activated medical device
08/16/2007WO2007092088A1 Compositions comprising amphotericin b
08/16/2007WO2007092031A1 Stable pharmaceutical formulations of montelukast sodium
08/16/2007WO2007092026A1 Dipyridamole extended-release formulations and process for preparing same
08/16/2007WO2007091661A1 Sugar chain-modified liposome suitable for molecular imaging and utilization and production of the same
08/16/2007WO2007091580A1 Novel vaccine carrier
08/16/2007WO2007091489A1 Laminated microcapsule sheet producing apparatus
08/16/2007WO2007091279A1 Formulations of clopidogrel bisulphate
08/16/2007WO2007091109A1 Pharmaceutical composition comprising tacrolimus
08/16/2007WO2007091059A1 Preparation and composition of a solid dosage form containing tacrolimus and/or sirolimus
08/16/2007WO2007090897A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
08/16/2007WO2007090883A1 Extended release formulation
08/16/2007WO2007090882A2 Pharmaceutical extended release compositions comprising pramipexole
08/16/2007WO2007090870A1 Process for preparing a particle comprising a biological molecule and a carrier polymer
08/16/2007WO2007090846A1 Haemostatic agent
08/16/2007WO2007090721A1 Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water
08/16/2007WO2007090676A1 Subtituted organopolysiloxanes and use thereof
08/16/2007WO2007090646A1 Nebulised antibiotics for inhalation therapy
08/16/2007WO2007090595A1 Solid formulations of valacyclovir hydrochloride
08/16/2007WO2007090393A2 Microtablet-based pharmaceutical preparation
08/16/2007WO2007090255A2 Polymeric implant and a process for obtaining a polymeric implant
08/16/2007WO2007076053A3 Stable s-nitrosothiol formulations
08/16/2007WO2007075794A3 Oral formulations comprising tigecycline
08/16/2007WO2007075502A9 Thermo-responsive block co-polymers, and use thereof
08/16/2007WO2007074472A3 Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide
08/16/2007WO2007072535A3 Microparticulate systems for the oral administration of biologically active substances
08/16/2007WO2007068948A3 Pharmaceutical sustained release compositions comprising in particular thyroid hormones
08/16/2007WO2007067964A3 Mucosal delivery of stabilized formulations of exendin
08/16/2007WO2007067784A3 Liposomal compositions
08/16/2007WO2007060108A3 Aerosol formulation for inhalation containing an anticholinergic agent
08/16/2007WO2007060104A3 Aerosol formulation for inhalation containing an anticholinergic agent
08/16/2007WO2007057598A3 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof
08/16/2007WO2007050181A3 Metal coordinated compositions
08/16/2007WO2007049279A3 A liposomal combination and uses thereof
08/16/2007WO2007042262A3 Ophthalmic emulsions containing prostaglandins
08/16/2007WO2007036952A3 Novel sustained release dosage form
08/16/2007WO2007036278A3 Method for stabilising pharmaceutical administration forms that contain micro-organisms
08/16/2007WO2007025764A3 Pharmaceutical formulations for salts of monobasic acids comprising clopidogrel
08/16/2007WO2007016388A3 Liquid formulations for controlled delivery of benzisoxazole derivatives
08/16/2007WO2006133349A3 Orally disintegrable sleep aid formulations
08/16/2007WO2006020841A3 Apparatus and method for transdermal delivery of natriuretic peptides
08/16/2007WO2005012489A3 Targeting endothelium for tissue-specific delivery of agents
08/16/2007WO2003087339A3 Spray freeze dry of compositions for pulmonary administration
08/16/2007US20070191819 Cell processor for use in the treatment of diseases
08/16/2007US20070191818 Osmotic pump with means for dissipating internal pressure
08/16/2007US20070191817 Dosage control for drug delivery system
08/16/2007US20070191816 Radio frequency induced drug elution
08/16/2007US20070191815 Biosynchronous transdermal drug delivery
08/16/2007US20070191792 Device for dosing a product that is intended to be applied to the skin
08/16/2007US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds
08/16/2007US20070191412 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
08/16/2007US20070191404 Pharmaceutical compositions of pyrimidine-2,4,6-triones
08/16/2007US20070191320 Methods of treatment for female sexual arousal disorder
08/16/2007US20070191286 Injectable composition
08/16/2007US20070191279 Administering adenosine A1 receptor antagonist 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine(CVT-124) for modulating osteoclastogenesis and for treating bone diseases characterized by bone loss or a decrease in bone mass or density
08/16/2007US20070190603 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
08/16/2007US20070190163 Technology for preparation of macromolecular microspheres
08/16/2007US20070190162 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
08/16/2007US20070190161 Solid formulation for dialysis and process for producing the same
08/16/2007US20070190160 Nanoparticles for drug-delivery
08/16/2007US20070190159 Polyamino acid-based insulin preparation
08/16/2007US20070190158 Pharmaceutical compositions in particulate form
08/16/2007US20070190157 Film lined packaging and method of making same
08/16/2007US20070190156 Ion channel modulating compounds and uses thereof
08/16/2007US20070190155 Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery
08/16/2007US20070190154 Method for the production of emulsion-based micro particles
08/16/2007US20070190153 Delivery systems for non-steroidal anti-inflammatory drugs (nsaids)
08/16/2007US20070190152 Method for providing an active agent topically to the skin
08/16/2007US20070190151 Method of preparing dendritic drugs
08/16/2007US20070190150 Polymer actuator
08/16/2007US20070190149 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
08/16/2007US20070190148 Gel compositions, apparatuses and fluid separation methods
1 ... 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 ... 2991